AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Herclon 150mg Injection

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Trastuzumab (150mg)

Overview Herclon 150mg Injection

Oncaspar 150mg Injection treats breast and gastric cancers by targeting and eliminating cancerous cells through HER2 (human epidermal growth factor receptor 2) inhibition. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your individual needs and may vary. Adhere strictly to your doctor's instructions; incorrect usage or overdose can lead to severe complications. Therapeutic benefits may not be apparent for weeks or months; discontinue use only under medical supervision. Common side effects include nausea, headache, skin rash, sleep disturbances, and infections. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests monitoring blood cell levels, cardiac function, liver health, and uric acid are necessary. Report shortness of breath, cough, chills, or limb swelling immediately. Inform your healthcare provider of all other medications you're taking, as interactions may occur. Pregnancy and breastfeeding are contraindicated; reliable contraception is crucial for both partners during treatment. A patient support program exists in India, managed by Tata 1mg; consult your doctor or call (1800-102-1618) for further information.

Uses of Herclon 150mg Injection

Cancers affecting the breast and stomach.

Major Benefits of Herclon 150mg Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Herclon 150mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Herclon 150mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Herclon 150mg Injection works:

The injectable medication Herclon 150mg, a genetically engineered IgG1 monoclonal antibody, targets HER2 (human epidermal growth factor receptor 2) receptors. By binding to these receptors, overactive in breast and stomach cancers, Herclon prevents the uncontrolled growth of cancer cells. This action is achieved through direct inhibition of HER2 and the subsequent disruption of several downstream signaling pathways that promote cancer development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Herclon 150mg Injection and alcohol can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Herclon 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Herclon 150mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Herclon 150mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of Herclon 150mg Injection in individuals with kidney impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Herclon 150mg Injection to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Herclon 150mg Injection :

Should you forget a dose of Herclon 150mg Injection, seek advice from your physician.

Facts to Know About Herclon 150mg Injection

LabelValue
Chemical Type Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Drugs
Action Class Monoclonal Antibody HER2/neu (ErbB2) Inhibitor

FAQs on Herclon 150mg Injection

Herclon 150mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, unusual bruising or bleeding, stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea, vomiting, loss of appetite, rapid heartbeat, discolored or decreased urine, painful urination, and other signs of infection. Contact your doctor immediately if you experience any of these symptoms.
Women of childbearing age must use reliable contraception throughout Herclon 150mg Injection therapy and for seven months afterward. Pregnancy planning can resume seven months post-treatment.
Treatment with Herclon 150mg Injection for early-stage breast cancer should continue for one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Herclon 150mg Injection does not require fasting beforehand. Administration must be supervised by a physician experienced in administering cancer chemotherapy, and should only be given by a qualified healthcare professional.
Herclon 150mg Injection is available in two formulations: intravenous (IV) infusion and subcutaneous injection. Always verify the correct formulation is administered as prescribed, as the IV formulation is not for subcutaneous use. Your doctor may change your treatment between IV and subcutaneous Herclon 150mg Injection if clinically appropriate.
Herclon 150mg Injection, a monoclonal antibody, targets the HER2 protein found on some cancer cells. Because it works by binding to HER2 to inhibit cancer growth, it's only effective in patients with HER2-positive cancer; it is not indicated for use in HER2-negative cases.
Using Herclon 150mg Injection with anthracyclines (like doxorubicin) can harm your heart. Your doctor must assess your heart health before and during treatment.
Cardiac evaluations are required at treatment initiation, every three months during treatment, and every six months post-treatment for 24 months following the final Herclon 150mg Injection dose. Patients with pre-existing cardiac conditions require evaluations every 12 weeks.
Herclon 150mg Injection
14,274
MRP 17,390
17% off